Structural insights into the Argonaute-containing CDK8 complex
对含有 Argonaute 的 CDK8 复合物的结构见解
基本信息
- 批准号:10279341
- 负责人:
- 金额:$ 33.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAntineoplastic AgentsArchitectureBindingBiochemicalCardiovascular DiseasesColorectal CancerComplexCryoelectron MicroscopyDNA Polymerase IIDNA-Directed RNA PolymeraseDataDevelopmentDiseaseEukaryotaFoundationsFunctional disorderGene ExpressionGene Expression RegulationGenetic TranscriptionGenomeGoalsHumanInvestigationKnowledgeLightLinkMalignant NeoplasmsMediatingMediator of activation proteinMolecularMutateMutationNeurodevelopmental DisorderNucleic Acid BindingNucleic AcidsOncoproteinsPathogenicityPhosphorylationPhosphotransferasesPropertyProteinsRecurrenceRegulationResearchResolutionRoleSignal TransductionStructureTranscriptional RegulationYeastsbasedrug developmenthuman diseaseinhibitor/antagonistinsightkinase inhibitormalignant breast neoplasmnext generation sequencingnovelnovel therapeuticsparticleprotein complextranscription factortumor
项目摘要
Abstract
In eukaryotes, transcription Mediator contains a dissociable Cdk8 kinase module (CKM) that regulates gene
expression through kinase-dependent and -independent functions. The human CKM consists of Med13,
Med12, Cdk8, and CycC subunits, which are either mutated or amplified in neurodevelopmental disorders and
multiple cancers, such as breast and colorectal cancers. Despite extensive links between CKM and human
diseases, the fundamental mechanisms of CKM in regulation of gene transcription remain poorly understood.
The long-term goal is to elucidate the molecular mechanisms by which CKM regulates gene transcription
through its kinase function and nucleic acid interactions. The overall objectives in this application are to (i)
reveal the structure basis and functional roles of CKM subunits, (ii) elucidate the activation mechanism of Cdk8
and the way in which it recognizes substrates for phosphorylation, and (iii) investigate the functional
interactions between Med13 and nucleic acids. Three aims are proposed in this application. Aim 1 is to
uncover the high-resolution structure of yeast CKM and understand how Cdk8 becomes activated by Med12
and binds substrates. We will use single-particle cryo-EM to reveal
interactions
how
the
targets
the overall structure of yeast CKM and its
with Cdk8 substrates. We will use biochemical approaches to elucidate the detailed mechanism of
Cdk8 kinase is activated by Med12 through a non-canonical mechanism. In Aim 2 , we will characterize
nucleic acid binding properties of Med13 using biochemical approaches as well as identify its binding
using next-generation sequencing. In Aim 3, we willuse our detailed knowledge of yCKM to reinforce
our knowledge gained from studies of human CKM's structure, substrate binding, and disease mutations.
proposed
kinase
regulation
The
studies are significant because they will provide valuable structural and functional insights into the
function and nucleic acids interaction of CKM revealing the fundamental mechanisms of CKM in
of gene expression. Ultimately, our results will offer
,
a structural foundation for development of
kinase inhibitors to treat Cdk8-driven human diseases.
摘要
在真核生物中,转录介体包含一个可分离的Cdk 8激酶模块(CKM),
通过激酶依赖性和非依赖性功能表达。人CKM由Med 13组成,
Med 12、Cdk 8和CycC亚基,它们在神经发育障碍中突变或扩增,
多种癌症,如乳腺癌和结肠直肠癌。尽管CKM和人类之间存在广泛的联系,
尽管CKM在疾病中的作用机制尚不清楚,但CKM在基因转录调控中的基本机制仍知之甚少。
长期目标是阐明CKM调节基因转录的分子机制
通过其激酶功能和核酸相互作用。本申请的总体目标是(i)
揭示CKM亚基的结构基础和功能作用;(ii)阐明Cdk 8的激活机制
以及它识别磷酸化底物的方式,以及(iii)研究功能性
Med 13与核酸之间的相互作用。本申请提出了三个目标。目标1:
揭示酵母CKM的高分辨率结构,并了解Cdk 8如何被Med 12激活
并结合底物。我们将使用单粒子低温电镜来揭示
相互作用
如何
的
目标
酵母CKM整体结构及其
Cdk 8基板我们将使用生物化学的方法来阐明详细的机制,
Cdk 8激酶通过非经典机制被Med 12激活。在目标2中,我们将描述
Med 13的核酸结合特性,并鉴定其结合
使用下一代测序技术在目标3中,我们将使用yCKM的详细知识来加强
我们的知识来自对人类CKM结构、底物结合和疾病突变的研究。
提出
激酶
调控
的
研究是重要的,因为它们将提供有价值的结构和功能的见解,
CKM的功能和核酸相互作用,揭示CKM在
的基因表达。最终,我们的结果将提供
,
发展的结构基础
激酶抑制剂来治疗Cdk 8驱动的人类疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kuang-Lei Tsai其他文献
Kuang-Lei Tsai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kuang-Lei Tsai', 18)}}的其他基金
Structural insights into the Argonaute-containing CDK8 complex
对含有 Argonaute 的 CDK8 复合物的结构见解
- 批准号:
10664974 - 财政年份:2021
- 资助金额:
$ 33.71万 - 项目类别:
Structural insights into the Argonaute-containing CDK8 complex
对含有 Argonaute 的 CDK8 复合物的结构见解
- 批准号:
10456265 - 财政年份:2021
- 资助金额:
$ 33.71万 - 项目类别:
相似海外基金
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
- 批准号:
9975367 - 财政年份:2020
- 资助金额:
$ 33.71万 - 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
- 批准号:
16K11932 - 财政年份:2016
- 资助金额:
$ 33.71万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
- 批准号:
19591274 - 财政年份:2007
- 资助金额:
$ 33.71万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
- 批准号:
6346309 - 财政年份:2000
- 资助金额:
$ 33.71万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
2885074 - 财政年份:1999
- 资助金额:
$ 33.71万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
6174221 - 财政年份:1999
- 资助金额:
$ 33.71万 - 项目类别: